Dr. Agarwals Health Care Limited
Book Built Issue IPO · NSE, BSE
- Price band
- ₹382 - ₹402
- Lot size
- 35 shares
- Issue amount
- ₹3,027.26 cr
- Total subscription
- 1.55×
- Opens
- 29 Jan 2025
- Closes
- 31 Jan 2025
- Allotment
- 1 Feb 2025
- Listing
- 4 Feb 2025
Offer at a glance
Issue overview
- Issue size
- 7,53,04,970 shares
- Face value
- ₹1 Per Equity Share
- Minimum investment
- ₹13,370
- Fresh issue
- ₹300 cr
- Offer for sale
- ₹2,727.26 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,070
- Issue type
- Book Built Issue IPO
- Shares before issue
- 30,75,55,920
- Shares after issue
- 31,58,79,846
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 35 | ₹14,070 |
| sHNI | 15 | 525 | ₹2,11,050 |
| bHNI | 15 | 525 | ₹2,11,050 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 7,25,960 | 2,16,584 |
| HNIs(10L +) | 13,828 | 846 |
| HNIs (2-10L) | 6,914 | 3,432 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 583.67 | 2,707.92 |
| RETAIL | 1,021.43 | 423.72 |
| HNIs 2+ | 145.92 | 81.26 |
| HNIs 10+ | 291.84 | 91.9 |
| EMPLOYEES | 63.49 | 17.11 |
| Shareholder | 45.41 | 23.47 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 1 | 3.13 | 4 |
| ROE | 2.69 | 9.33 | 23.12 |
| ROCE | 8.3 | 14.61 | 15.18 |
| RONW | 1.9 | 6.21 | 14.99 |
| PRE IPO(PE) | 0 | 130.44 | 0 |
| POST IPO(PE) | 160.48 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.
Strengths
- Strong Brand Reputation: Known as a top provider of eye care, the company has built a trusted brand among patients.
- Cutting-Edge Technology: Uses the latest technologies to ensure precise and effective treatments.
- Global Reach: Has a large network of hospitals both in India and around the world.
Risk factors
- Tough Competition: The healthcare sector is highly competitive, with pressure to keep prices competitive.
- Regulatory Requirements: The company must follow strict medical and financial regulations.
- Operational Challenges: Relies on skilled staff and faces the risk of equipment becoming outdated.
Promoters
Dr. Amar Agarwal,
Dr. Athiya Agarwal
Dr Adil Agarwal
Dr. Anosh Agarwal
Dr Ashvin Agarwal
Dr. Ashar Agarwal
Dr. Amar Agarwal Family Trust
Dr Adil Agarwal Family Trust
Dr. Anosh Agarwal Family Trust
Dr Ashvin Agarwal Family Trust
Dr. Ashar Agarwal Family Trust
Dr Agarwal’s Eye Institute
Dr Agarwal's Eye Institute Private Limited
Registrar & documents
Lead manager
Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
1 st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006
+91 44 4378 7777
[email protected]Company website ↗Understanding AGARWALEYE IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.